Oura's CEO talks healthcare, but the real story behind wearable technology is data monetization and medical gatekeeping.
NYC Health + Hospitals celebrates a milestone in **robotic-assisted bronchoscopy**. But behind the PR spin lies a critical debate on medical technology adoption and cost.
Forget missiles. Taiwan's true global leverage lies in **semiconductor manufacturing**. This is the real choke point.
Adaptive gaming technology is heralded as a revolution, but we must analyze the true winners and losers in this new era of inclusive digital interaction.
The battle over **digital health** data just got personal. A Swedish government developer is exposing the rot beneath the surface of consumer **mHealth apps**, revealing a crisis of trust in **healthcare technology**.
Forget the sci-fi dream. Integrated exoskeleton technology is a Trojan horse for industrial control, not human augmentation.
OpenAI's entry into healthcare isn't about better diagnoses; it's a calculated move to shift medical accountability. We analyze the real winners and losers in this AI power grab.
The FDA's new oversight rules for AI and wearables aren't about safety—they're about control. Unpacking who truly benefits from this regulatory shift.
Forget the flashy gadgets. Ambarella's upcoming CES 2026 briefing signals a massive pivot in edge AI processing, and the implications for consumer privacy are chilling.
Forget clinical trials. The rise of DIY medical hardware, especially for chronic conditions like tremors, signals a massive shift in healthcare power dynamics.
The mass departure of key FDA digital health leaders signals a regulatory vacuum. Discover the hidden power shift in digital health innovation.
The FDA's Digital Health Center of Excellence sounds benign, but it signals a massive, unaddressed shift in **digital health regulation** and **telemedicine adoption**.